Spironolactone is a medication usually used for fluid retention, but doctors sometimes use it to treat androgenetic alopecia, a type of hair loss in females. Spironolactone (Aldactone) is a type ...
Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture its generic version of Paliperidone extended-release tablets, used to treat ...
Nippon India Small Cap Fund - Direct (G) 560.96 28,45,731 0.91 Nippon India Small Cap Fund - Direct (B) 560.96 28,45,731 0.91 Nippon India Small Cap Fund (B) 560.96 ...
Zydus Lifesciences Q3 Earnings: Zydus Lifesciences reported a 30% YoY rise in Q3FY25 net profit to ₹1,023.5 crore, driven by strong US growth. Revenue increased 17% YoY, while EBITDA rose 26%. The ...
Zydus Wellness Ltd. is a Public Limited Listed company incorporated on 01/11/1994 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is ...
Nomura has upgraded Zydus Lifesciences Ltd. to a 'buy' from its earlier 'neutral' stance, raising the target price to Rs 1,140 from Rs 1,030, implying a potential upside of 16%. Robust earnings growth ...
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...
Zydus Wellness Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 11,392.70 Crore) operating in FMCG sector. Zydus Wellness Ltd. key Products/Revenue Segments include ...
Zydus Lifesciences Limited reported a 30 per cent year-on-year increase in net profit to ₹1,023.5 crore for the quarter ended December 31, 2024, driven by robust performance in its US ...
Zydus Lifesciences Ltd. said on Wednesday that the US Food and Drug Administration granted its underdevelopment drug Usnoflast the orphan drug designation, according to an exchange filing on Wednesday ...